Laura Sichlinger

Laura Sichlinger

Auto-generated profile, based on publicly available information

Laura Sichlinger

Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2025 in bioRxiv
Verified
Preprint
Open access
LSLaura Sichlinger
Laura Sichlinger
MRMolly B. Reilly
Molly B. Reilly
SASakshi Arora
Sakshi Arora
SZShuo Zhang
Shuo Zhang
NMNicolas Marotta
Nicolas Marotta
EHElizabeth Heller
Elizabeth Heller
Synaptic Ras GTPase-activating protein (SynGAP) regulates synaptic strength and neuronal signaling, with essential roles in cortical development and synaptic plasticity. Heterozygous loss-of-function variants in SYNGAP1 cause SYNGAP1 -related intellectual disability (SRID), a severe neurodevelopmental disorder characterized by epilepsy, developmental delay, and autism. SYNGAP1 mutations often result in haploinsufficiency, providing a strong rationale for gene-targeted therapies. However, no treatment currently addresses the underlying genetic cause of SRID. Here, we developed a CRISPR-mediated transcriptional activation (CRISPRa) approach to upregulate the functional Syngap1 allele in a SRID mouse model. CRISPRa activated Syngap1 , normalized SynGAP protein expression and downstream signaling, and rescued working memory deficits. We validated the translational potential of this strategy in human induced pluripotent stem cell (hiPSC)-derived excitatory cortical neurons. CRISPRa rescued SYNGAP1 in two distinct loss-of-function variant lines. Together, these findings demonstrate the feasibility of mutation-independent transcriptional activation as a therapeutic approach for SRID and its broader applicability to haploinsufficiency disorders.

17 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PRPooja Raval
Pooja Raval
HRHannah Rae
Hannah Rae
RDRodrigo R. R. Duarte
Rodrigo R. R. Duarte
IWIain A. Watson
Iain A. Watson
KSKatherine J. Sellers
Katherine J. Sellers
DSDeepak P. Srivastava
Deepak P. Srivastava
Estrogens, specifically 17β-estradiol (estradiol), can modulate synaptic function by regulating the expression and localisation of synaptic proteins. However, the mechanisms underlying estradiol’s regulation of synaptic protein expression, and whether if they occur in a sex specific manner, is not well understood. In this study, using sex-specific hippocampal slice cultures and mixed-sex primary hippocampal neurons, we investigated whether local protein synthesis is required for estradiol- induced synaptic protein expression. Estradiol rapidly increased the rate of protein synthesis and the number of actively translating ribosomes along dendrites and near synapses in both male and female hippocampal neurons. Importantly, these effects occurred independently of gene transcription. Moreover, estradiol also increased the abundance of nascent proteins localised to synapses, independently of gene transcription. Specifically, estradiol increased the synaptic expression of GluN2B- containing N -methyl-D-aspartate receptors and PSD-95 in male and female hippocampus. Mechanistically, mTOR signalling was required for estradiol-induced increases in overall local protein synthesis only in male but not female hippocampus. Consistent with this, mTOR signalling mediated estradiol increases in GluN2B in male, but not female, hippocampus. Conversely, mTOR inhibition, blocked estradiol-induced increased PSD-95 expression in both male and female hippocampus. Collectively, these data suggest that the rapid modulation of local protein synthesis by estradiol is required for changes in the synaptic proteome in male and female hippocampus, and that the requirement of the mTOR signalling pathway in these effects occur in both a sex-specific and protein-dependent manner, with this signalling pathway have a greater role in male compared to female hippocampus.

22 May 2026 in Science Advances
Verified
Journal Article
Open access
LSLaura Sichlinger
Laura Sichlinger
MHMaximilian Hausherr
Maximilian Hausherr
SGSara Guerrisi
Sara Guerrisi
LDLucia Dutan-Polit
Lucia Dutan-Polit
GCGeorge Chennell
George Chennell
DSDeepak P. Srivastava
Deepak P. Srivastava
ZNF804A was among the first genes robustly associated with schizophrenia based on findings from large-scale genomic studies. Previous research has implicated ZNF804A in the regulation of gene expression and synaptic function, but the role of this gene in neurodevelopment and in schizophrenia pathogenesis remains unclear. To study its function during neurodevelopment, we generated isogenic human induced pluripotent stem cells with reduced ZNF804A expression, differentiated them into developing cortical glutamatergic neurons, and studied their transcriptomic, synaptic, and protein signatures. Mutant neurons showed modest evidence for changes in gene expression. However, high-content confocal imaging revealed increased excitatory synapse density in mutant neurons. Cell compartment–specific proteomic analysis further revealed that mutant neurons had higher levels of ribosomal and translational proteins within neurites, and high-content imaging confirmed increased local protein synthesis efficiency. Overall, these results demonstrate that in human developing cortical glutamatergic neurons, ZNF804A regulates excitatory synapse formation potential via increased local protein translation.

1 March 2019 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
PDF file
LSLaura Sichlinger
Laura Sichlinger
ECEmily Cibelli
Emily Cibelli
MGMatthew Goldrick
Matthew Goldrick
VMVijay Mittal
Vijay Mittal
Previous studies of speech abnormalities in schizophrenia reflect a consensus that atypical turn-taking behavior during conversation is a prominent feature of speech patterns in psychosis. However, the literature focuses on the population with formal psychosis and lacks studies that involve individuals who are at clinical high-risk (CHR) for developing a psychotic disorder. This study assessed the turn-taking performance of CHR youth to evaluate if abnormalities in turn-taking can be observed in the CHR population compared with controls and to investigate if turn-taking performance is correlated with symptom severity. While analysis of speech data from structured clinical interviews shows no significant group effects, high scores in attenuated psychosis symptoms were associated with significantly longer between turn pauses in the CHR population. This study adds to a growing body of literature that suggests that patterns of speech and linguistic features may be useful in detecting risk, and tracking clinical and treatment course across schizophrenia and spectrum disorders.

1 December 2021 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
LSL. Sichlinger
L. Sichlinger
AAA. Aabdien
A. Aabdien
PRP. Raval
P. Raval
LTL. Tanangonan
L. Tanangonan
AVA. Vernon
A. Vernon
DSD. Srivastava
D. Srivastava

27 September 2021 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
LSLaura Sichlinger
Laura Sichlinger
AAAfra Aabdien
Afra Aabdien
PRPooja Raval
Pooja Raval
AVAnthony Vernon
Anthony Vernon
DSDeepak Srivastava
Deepak Srivastava